• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall KY TINGLING JELLY Personal Lubricant.

  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

New Search Back to Search Results
 Class 2 Device Recall KY TINGLING JELLY Personal Lubricant. see related information
Date Posted February 22, 2013
Recall Status1 Terminated on April 11, 2014
Recall Number Z-0875-2013
Recall Event ID 64322
Product Classification Lubricant, personal - Product Code NUC
Product KY TINGLING JELLY Personal Lubricant. The product is packaged into 5 oz tubes with the UPC printed on it. Distributed By: McNeil-PPC Inc.
Code Information Tube UPC: 380040088887
Case Code(s): 008888 V21, 008888 V00
Outer Case UPC: 103800400888840215, 103800400888840000
Recalling Firm/
199 Grandview Rd
Skillman NJ 08558-1311
For Additional Information Contact Stericycle
Manufacturer Reason
for Recall
This product is not cleared for marketing in the US.
FDA Determined
Cause 2
No Marketing Application
Action Johnson and Johnson Healthcare Products sent recall notification letters dated 1/25/2013 to its customers (retailers and wholesalers). The letter identified the product, problem, and actions to be taken by the customers. Customers were asked to return all cases of affected product in their possession. The letter included delivery confirmation and a return packing slip, return authorization label and business reply card. Contact J & J Sales & Logistics at 866-912-8414 for questions regarding the return of affected product. Contact your J & J Sales & Logistics Company Sales Representative for questions about the product.
Quantity in Commerce 425,304 units
Distribution Nationwide Distribution.
Total Product Life Cycle TPLC Device Report

1 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.